• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔舌鳞癌患者接受(放)化疗的预后组织学标志物。

Prognostic histological markers in oral tongue squamous cell carcinoma patients treated with (chemo)radiotherapy.

机构信息

Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.

Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

出版信息

APMIS. 2023 Apr;131(4):142-151. doi: 10.1111/apm.13298. Epub 2023 Feb 13.

DOI:10.1111/apm.13298
PMID:36695633
Abstract

Treatment of oral tongue squamous cell carcinoma (OTSCC) frequently includes surgery with postoperative radiotherapy (RT) or chemoradiotherapy (CRT). Resistance to RT or CRT remains a major clinical challenge and highlights the need to identify predictive markers for it. We included 71 OTSCC patients treated with surgery combined with RT or CRT. We evaluated the association between tumor budding, tumor-stroma ratio (TSR), depth of invasion (DOI), tumor-infiltrating lymphocytes (TILs), hypoxia-inducible factor-1alpha (HIF-1alpha) expression, octamer-binding transcription factor 4 (OCT4) expression, high-endothelial venules (HEVs), and disease-free survival (DFS) using uni- and multivariate analyses. No significant association was observed between the different histological and molecular markers (TSR, DOI, TILs, HEV, HIF-1alph, OCT4) and DFS. However, an associative trend between DOI, budding, and DFS was noted. Further studies with larger cohorts are needed to explore the prognostic value of DOI and budding for OTSCC patients treated with postoperative RT or CRT.

摘要

口腔舌鳞状细胞癌(OTSCC)的治疗常包括手术联合术后放疗(RT)或放化疗(CRT)。对 RT 或 CRT 的耐药性仍然是一个主要的临床挑战,这凸显了确定其预测标志物的必要性。我们纳入了 71 例接受手术联合 RT 或 CRT 治疗的 OTSCC 患者。我们使用单变量和多变量分析评估了肿瘤芽殖、肿瘤-基质比(TSR)、浸润深度(DOI)、肿瘤浸润淋巴细胞(TILs)、缺氧诱导因子-1alpha(HIF-1alpha)表达、八聚体结合转录因子 4(OCT4)表达、高内皮静脉(HEVs)与无病生存(DFS)之间的相关性。不同的组织学和分子标志物(TSR、DOI、TILs、HEV、HIF-1alpha、OCT4)与 DFS 之间无显著相关性。然而,DOI、芽殖与 DFS 之间存在关联趋势。需要进一步的大样本研究来探讨 DOI 和芽殖对接受术后 RT 或 CRT 治疗的 OTSCC 患者的预后价值。

相似文献

1
Prognostic histological markers in oral tongue squamous cell carcinoma patients treated with (chemo)radiotherapy.口腔舌鳞癌患者接受(放)化疗的预后组织学标志物。
APMIS. 2023 Apr;131(4):142-151. doi: 10.1111/apm.13298. Epub 2023 Feb 13.
2
Tumour-stroma ratio is a valuable prognostic factor for oral tongue squamous cell carcinoma.肿瘤间质比是口腔舌鳞状细胞癌有价值的预后因素。
Oral Dis. 2023 Mar;29(2):628-638. doi: 10.1111/odi.14013. Epub 2021 Sep 28.
3
Tumor-stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade.肿瘤间质比可预测 cT1/2N0 口腔舌鳞癌的淋巴结转移,与肿瘤芽分级无关。
Int J Clin Oncol. 2022 Dec;27(12):1818-1827. doi: 10.1007/s10147-022-02249-y. Epub 2022 Oct 5.
4
Prognostic outcomes of treatment naïve oral tongue squamous cell carcinoma (OTSCC): a comprehensive analysis of 14 years.初治口腔舌鳞癌(OTSCC)的预后结果:14 年的综合分析。
Eur Arch Otorhinolaryngol. 2021 Aug;278(8):3045-3053. doi: 10.1007/s00405-020-06482-x. Epub 2020 Nov 25.
5
Prognostic significance of tumor budding thresholds in oral tongue squamous cell carcinoma.肿瘤芽殖阈值对口腔舌鳞状细胞癌的预后意义。
Oral Dis. 2023 Jul;29(5):1947-1958. doi: 10.1111/odi.14193. Epub 2022 Apr 16.
6
Addition of the tumour-stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma.肿瘤间质比与第 8 版美国癌症联合委员会分期系统联合应用可提高口腔舌鳞癌患者的生存预测。
Histopathology. 2020 Nov;77(5):810-822. doi: 10.1111/his.14202. Epub 2020 Sep 12.
7
Prognostic Role of Tumor-Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma.肿瘤浸润淋巴细胞和肿瘤芽殖在早期口腔舌癌中的预后作用
Laryngoscope. 2021 Nov;131(11):2512-2518. doi: 10.1002/lary.29589. Epub 2021 May 6.
8
Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.早期口腔舌癌中肿瘤间质比的预后影响。
Histopathology. 2018 Jun;72(7):1128-1135. doi: 10.1111/his.13481. Epub 2018 Mar 23.
9
The prognostic value of immunohistochemical markers for oral tongue squamous cell carcinoma.口腔舌鳞状细胞癌免疫组化标志物的预后价值
Eur Arch Otorhinolaryngol. 2015 Oct;272(10):2953-9. doi: 10.1007/s00405-014-3254-5. Epub 2014 Aug 29.
10
Comparative analysis of the efficacy of definitive chemoradiation therapy and surgery followed by adjuvant radiation therapy in advanced-stage oral tongue cancer.比较分析根治性放化疗与手术加辅助放疗治疗晚期舌癌的疗效。
Exp Oncol. 2020 Sep;42(3):228-232. doi: 10.32471/exp-oncology.2312-8852.vol-42-no-3.14873.

引用本文的文献

1
Genetic associations of polymorphisms with clinicopathologic characteristics of tongue cancer.多态性与舌癌临床病理特征的遗传关联。
Int J Med Sci. 2025 Feb 18;22(5):1208-1214. doi: 10.7150/ijms.103842. eCollection 2025.
2
Prognostic Significance of Tumor-Stroma Ratio (TSR) in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.肿瘤间质比(TSR)在头颈部鳞状细胞癌中的预后意义:系统评价和荟萃分析。
Cells. 2024 Oct 26;13(21):1772. doi: 10.3390/cells13211772.
3
Predicting radiotherapy efficacy and prognosis in tongue squamous cell carcinoma through an in-depth analysis of a radiosensitivity gene signature.
通过对放射敏感性基因特征的深入分析预测舌鳞状细胞癌的放射治疗疗效和预后。
Front Oncol. 2024 Aug 26;14:1334747. doi: 10.3389/fonc.2024.1334747. eCollection 2024.
4
Intratumoral high endothelial venules in solid tumors: a pooled study.实体瘤内高内皮静脉:荟萃研究。
Front Immunol. 2024 Jul 8;15:1401118. doi: 10.3389/fimmu.2024.1401118. eCollection 2024.